Following people with epilepsy-dyskinesia syndromes over time
Collects health data and samples from people with a genetic epilepsy-dyskinesia diagnosis.
Key facts
- Who runs it
- Boston Children's Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Registry and Natural History of Epilepsy-Dyskinesia Syndromes
- Status
- Recruiting
- People taking part
- 700 people, planned
- Started
- 1 Jun 2025
- Expected to end
- Jul 2030
- Type of study
- Observational
- Record updated
- 17 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with a genetic diagnosis of an epilepsy-dyskinesia syndrome. It collects health data and biological samples over time.
- Age
- 0 Years to 30 Years
- Sex
- All sexes
- Disease stage
- Epilepsy-dyskinesia syndromes with a genetic diagnosis.
- Biomarker or test result
- At least one pathogenic or likely pathogenic variant in one of the listed genes of interest (for example SCN1A, STXBP1, CDKL5, GNAO1, ATP1A3) or other genes linked to epilepsy-dyskinesia syndromes.
Main reasons for not taking part
- No pathogenic or likely pathogenic variant in the genes of interest
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Having at least one pathogenic or likely pathogenic variant in one of the genes of interest:; AARS2, ADCY5, ALG13, AP3B2, AP4B1, AP4E1, AP4M1, AP4S1, ARX, ATP1A3, CACNA1A, CACNA1E, CACNA2D2, CDKL5, CSTB, DARS2, DLAT, DLD, DNM1, EARS2, EPG5, EPM2A, FARS2, FOXG1, FRRS1L, GABRA1, GABRA2, GABRB2, GABRB3, GABRG2, GNAO1, GRIA2, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2D, HARS2, HNRNPU, HTT, IQSEC2, IRF2BPL, KCNA2, KCNB1, KCNC1, KCNMA1, KCNQ2, KCNQ3, KCNT1, LARS2, MECP2, MEF2C, MTND5, MTTK, MTTL1, NARS2, NHLRC1, PCDH12, PCDH19, PDE10A, PDE2, PDHA1, PDHB, PDHX, PDK3, PDP1, PIGA, PIGN, PIGP, PIGQ, PIGS, PLCB1, POLG, PRRT2, PURA, RHOBTB2, SCN1A, SCN1B, SCN2A, SCN8A, SCN9A, SETBP1, SETD5, SLC13A5, SLC1A2, SLC25A22, SLC2A1, SMC1A, SNX14, SPTAN1, ST3GAL3, STXBP1, SYNGAP1, SYNJ1, SZT2, TARS2, TBC1D24, UBA5, UBE3A, VAMP2, VARS2, WARS2, WDR45, WWOX, YIF1B, YWHAG, and other genes associated with epilepsy-dyskinesia syndromes
Who cannot take part
- Not having a pathogenic or likely pathogenic variants in the genes of interest
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 30 years old?
Where in United States
- Boston Children's HospitalBoston, United StatesContact: Darius Ebrahimi-Fakhari, MD, PhDTaking people
About the trial
What the trial wants to find out
The Registry and Natural History of Epilepsy-Dyskinesia Syndromes is focused on gathering longitudinal clinical data as well as biological samples (blood, urine, and/or skin/tissue) from male and female patients, of all ages, who have a genetic diagnosis of epilepsy-dyskinesia syndromes. Through prospective review and molecular data analysis, the study aims to identify patterns and correlations between movement and seizure disorders, uncovering genotype-phenotype relationships. The initiative's goals are to enhance understanding of epilepsy-dyskinesia syndromes, inform precision medicine approaches, and foster international collaboration.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Registry and Natural History of Epilepsy-Dyskinesia Syndromes
- Plain-language title
- Following people with epilepsy-dyskinesia syndromes over timeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06967727, who can take part
- Record updated
- 17 August 2025